Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068237 · ClinicalTrials.gov registry record · Phase 2
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00068237 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 49 participants.
The verdict
NCT00068237, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
RATIONALE: Moving a salivary gland out of the area that will undergo radiation therapy may protect the gland from side effects of radiation therapy and may prevent xerostomia (dry mouth). PURPOSE: Phase II trial to study the effectiveness of salivary gland surgery in preventing xerostomia in patients who are undergoing radiation therapy for head and neck cancer.
Interventions
- PROCEDURE salivary gland transfer
- RADIATION Post-operative radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2003-08 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068237
The ClinicalTrials.gov registry entry for NCT00068237 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which salivary gland transfer is the first listed.
NCT00068237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068237 about?
NCT00068237 is a clinical study titled "Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer". RATIONALE: Moving a salivary gland out of the area that will undergo radiation therapy may protect the gland from side effects of radiation therapy and may prevent xerostomia (dry mouth). PURPOSE: Phase II trial to study the effectiveness of salivary gland surgery in preventing xerostomia in patien...
What is the current status of trial NCT00068237?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2003-08. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00068237?
The interventions under investigation include: salivary gland transfer (PROCEDURE), Post-operative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00068237?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.